OAC
UTHR icon

OMERS Administration Corp’s United Therapeutics UTHR Stock Holding History

OMERS Administration Corp’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Sell
7,665
-4,976
-39% -$2.8M 0.02% 370
2026
Q1 		$7.5M Buy
12,641
+5,764
+84% +$2.87M 0.05% 174
2025
Q4 		$3.35M Buy
6,877
+1,133
+20% +$528K 0.02% 253
2025
Q3 		$2.41M Sell
5,744
-4,500
-44% -$1.51M 0.02% 350
2025
Q2 		$2.94M Buy
10,244
+1,300
+15% +$389K 0.02% 253
2025
Q1 		$2.76M Buy
8,944
+1,634
+22% +$560K 0.02% 273
2024
Q4 		$2.58M Sell
7,310
-3,802
-34% -$1.4M 0.02% 268
2024
Q3 		$3.98M Sell
11,112
-6,800
-38% -$2.3M 0.04% 198
2024
Q2 		$5.71M Buy
17,912
+15,412
+616% +$4.08M 0.05% 144
2024
Q1 		$574K Hold
2,500
– – 0.01% 196
2023
Q4 		$550K Buy
+2,500
New +$576K 0.01% 172
2019
Q2 		– Sell
-3,200
Closed -$389K – 481
2019
Q1 		$389K Buy
+3,200
New +$373K ﹤0.01% 313
2018
Q4 		– Sell
-19,000
Closed -$2.43M – 341
2018
Q3 		$2.43M Buy
+19,000
New +$2.35M 0.02% 224
2018
Q1 		– Sell
-16,100
Closed -$2.38M – 509
2017
Q4 		$2.38M Sell
16,100
-15,800
-50% -$2.01M 0.02% 231
2017
Q3 		$3.74M Buy
+31,900
New +$4.07M 0.04% 183
2016
Q4 		– Sell
-21,500
Closed -$2.54M – 542
2016
Q3 		$2.54M Buy
+21,500
New +$2.58M 0.05% 220
2014
Q4 		– Sell
-84,500
Closed -$10.9M – 450
2014
Q3 		$10.9M Buy
84,500
+32,800
+63% +$3.38M 0.32% 73
2014
Q2 		$4.58M Buy
51,700
+2,900
+6% +$279K 0.15% 104
2014
Q1 		$4.59M Buy
48,800
+12,100
+33% +$1.24M 0.15% 96
2013
Q4 		$4.15M Buy
+36,700
New +$3.31M 0.15% 80

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

OMERS Administration Corp's UTHR Position: Q2 2026 in Review

OMERS Administration Corp reduced its United Therapeutics (UTHR) stake by 39% in Q2 2026, selling an estimated $2.8M and leaving 7,665 shares worth $4.15M. The position accounts for 0.02% of the portfolio, ranked #370.

OMERS Administration Corp first reported a position in UTHR in Q4 2013 and has held it in 20 quarters since. The position peaked at $10.9M in Q3 2014. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • OMERS Administration Corp held 7,665 shares of United Therapeutics worth $4.15M as of Q2 2026.
  • OMERS Administration Corp sold 4,976 United Therapeutics shares in Q2 2026, an estimated $2.8M.
  • United Therapeutics made up 0.02% of OMERS Administration Corp's portfolio in Q2 2026, its #370 holding.
  • OMERS Administration Corp first reported a position in United Therapeutics in Q4 2013 and has held it in 20 quarters since.
  • OMERS Administration Corp's United Therapeutics position peaked at $10.9M in Q3 2014.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.